病理类医疗服务价格立项指南发布 AI辅助诊断“有价可循”

Core Viewpoint - The National Healthcare Security Administration of China has released a guideline that includes "artificial intelligence-assisted diagnosis" as an expanded item in pathology diagnosis, integrating it into the pricing structure of pathology diagnostic services [1] Group 1 - The guideline is titled "Guidelines for the Project Establishment of Pathological Medical Service Pricing (Trial)" [1] - Artificial intelligence-assisted diagnosis is now officially recognized as part of the pathology diagnostic pricing project [1]